These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12070536)

  • 21. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
    Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
    Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
    Morimoto S; Jo F; Maki K; Iwasaka T
    Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species difference in the contribution of T-type calcium current to cardiac pacemaking as revealed by r(-)-efonidipine.
    Tanaka H; Komikado C; Namekata I; Nakamura H; Suzuki M; Tsuneoka Y; Shigenobu K; Takahara A
    J Pharmacol Sci; 2008 May; 107(1):99-102. PubMed ID: 18460822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
    Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
    Ohashi N; Mitamura H; Ogawa S
    Drugs; 2009; 69(1):21-30. PubMed ID: 19192934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
    Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
    Lei B; Hitomi H; Mori T; Nagai Y; Deguchi K; Mori H; Masaki T; Nakano D; Kobori H; Kitaura Y; Nishiyama A
    J Pharmacol Sci; 2011; 117(2):98-105. PubMed ID: 21897055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
    Higashino R; Sato R; Jin H; Inoue N; Fukuta Y; Kurimoto T; Tamaki H
    J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ca(2+) channel inhibitor efonidipine decreases voltage-dependent K(+) channel activity in rabbit coronary arterial smooth muscle cells.
    Park MH; Son YK; Hong DH; Choi IW; Kim DJ; Lee H; Bang H; Na SH; Li H; Jo SH; Park WS
    Vascul Pharmacol; 2013; 59(3-4):90-5. PubMed ID: 23876554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
    Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
    Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling.
    Ohashi N; Mitamura H; Tanimoto K; Fukuda Y; Kinebuchi O; Kurita Y; Shiroshita-Takeshita A; Miyoshi S; Hara M; Takatsuki S; Ogawa S
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):386-92. PubMed ID: 15475838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
    Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
    Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
    Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF
    Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of T-type calcium channels in elderly human vascular function: A pilot randomized controlled trial.
    Iepsen UW; Hjortdal AR; Thuesen AD; Finsen SH; Hansen PBL; Mortensen SP
    Exp Physiol; 2024 May; 109(5):779-790. PubMed ID: 38445814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
    Isaka T; Ikeda K; Takada Y; Inada Y; Tojo K; Tajima N
    Eur J Pharmacol; 2009 Mar; 605(1-3):49-52. PubMed ID: 19168055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
    Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
    Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.